Clinical application of curcumin has been limited due to poor aqueous solubility and consequently minimal systemic bioavailability. We investigated the preparation of curcumin-loaded micelles based on amphiphilic Pluronic/Polycaprolactone (Pluronic/PCL) block copolymer, which proved to be efficient in enhancing curcumin’s aqueous solubility. Curcumin-loaded micelles of size below 200 nm was characterized by dynamic light scattering and transmission electron microscopy. The critical micelle concentration (CMC) of the amphiphilic polymer was determined using pyrene as a fluorescent probe. Hemolysis and aggregation studies were investigated to evaluate the blood compatibility of the micelles. Sodium dodecyl sulphate polyacrylamide gel electrophoresis was performed to study the stability of the micelles toward plasma proteins. In vitro cytotoxicity and cellular uptake of the curcumin-loaded micelles were demonstrated in colorectal adenocarcinoma (Caco2) cells. The results indicated that Pluronic/PCL micelles could be a promising candidate for curcumin delivery to cancer cells.
AllenTMCullisPR. Drug delivery systems: entering the mainstream. Science2004; 303: 1818–1822.
2.
FarokhzadOCLangerR. Impact of nanotechnology on drug delivery. ACS Nano2009; 3: 16–20.
3.
TatianaB. Multifunctional polymeric carriers for gene and drug delivery. Pharm Res2010; 27: 2257–2259.
4.
YounghoonKPaulDDavidACDennisED. Polymeric worm micelles as nano-carriers for drug delivery. Nanotechnology2005; 16: 484–491.
5.
TorchilinVP. Structure and design of polymeric surfactant-based drug delivery systems. J Contr Release2001; 73: 137–172.
6.
SuttonDNasongklaNBlancoEGaoJ. Functionalized micellar systems for cancer targeted drug delivery. Pharm Res2007; 24: 1029–1046.
7.
DansonSFerryDAlakhovVMargisonJKerrDJowleD. Phase I dose escalation and pharmacokinetic study of pluronic polymerbound doxorubicin (SP1049C) in patients with advanced cancer. Br J Cancer2004; 90: 2085–2091.
8.
MatsumuraYHamaguchiTUraTMuroKYamadaYShimadaY. Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br J Cancer2004; 91: 1775–1781.
9.
KimTYKimDWChungJYShinSGKimSCHeoDS. Phase I and pharmacokinetic study of Genexol-PM a cremophor-free, polymeric micelle formulated paclitaxel, in patients with advanced malignancies. Clin Cancer Res2004; 10: 3708–3716.
10.
MaedaHGreishKFangJ. The EPR effect and polymeric drugs: a paradigm shift for cancer chemotherapy in the 21st century. Adv Polym Sci2006; 193: 103–121.
11.
WeirNMSelvendiranKKutalaVKTongLVishwanathSRajaramM. Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK. Cancer Biol Ther2007; 6: 178–184.
12.
KuttanRBhanumathyPNirmalaKGeorgeMC. Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett1998; 29: 197–202.
13.
SinghSAggarwalBB. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J Biol Chem1995; 270: 4995–5000.
14.
KunnumakkaraABAnandPAggarwalBB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett2008; 269: 199–225.
15.
LiuJYLinSJLinJK. Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells. Carcinogenesis1993; 14: 857–861.
16.
SahuAKasojuNBoraU. Fluorescence study of the curcumin-casein micelle complexation and its application as a drug nanocarrier to cancer cells. Biomacromolecules2008; 9: 2905–2912.
17.
SahuABoraUKasojuNGoswamiP. Self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells. Acta Biomater2008; 4: 1752–1761.
18.
BishtSFeldmannGSoniSRaviRKarikarCMaitraA. Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy. J Nanobiotechnol2007; 5: 3–3.
MaGSongC. PCL/Poloxamer 188 blend microsphere for paclitaxel delivery: influence of Poloxamer 188 on morphology and drug release. J Appl Polym Sci2007; 104: 1895–1899.
21.
ChandanaMSanjeebKS. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials2010; 31: 6597–6611.
22.
SahuAKasojuNGoswamiPBoraU. Encapsulation of curcumin in Pluronic block copolymer micelles for drug delivery applications. J Biomater Appl2011; 25: 619–639.
23.
ChangXMacdonaldDAGoosenMFAMcauleyKB. Mechanism of polymerization in the presence of stannous octoate: the effect of hydroxy and carboxylic acid substances. J Polym Sci: Part A: Polym Chem1994; 32: 2965–2970.
DasRKKasojuNBoraU. Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine: Nanotech Biol Med2010; 6: 153–160.
26.
LeeDWPowersKBaneyR. Physicochemical properties and blood compatibility of acylated chitosan nanoparticles. Carb Polym2004; 58: 371–377.
27.
KainthanRKGnanamaniMGanguliMGhoshTBrooksDEMaitiS. Blood compatibility of novel water soluble hyperbranched polyglycerol-based multivalent cationic polymers and their interaction with DNA. Biomaterials2006; 27: 5377–5390.
28.
YenFLWuTHTzengCWLinLTLinCC. Curcumin nanoparticles improve the physicochemical properties of curcumin and effectively enhance its antioxidant and antihepatoma activities. J Agric Food Chem2010; 58: 7376–7382.
29.
LüFFangYand BlanchardGJ. Probing the microenvironment of surface-attached pyrene formed by a thermo-responsive oligomer. Spectrochim Acta A Mol Biomol Spectrosc2009; 74: 991–999.
30.
XiongXYTamKCGanLH. Synthesis and thermally responsive properties properties of novel Pluronic F87/Polycaprolactone (PCL) block copolymers with short PCL blocks. J Appl Polym Sci2006; 100: 4163–4172.
31.
MohantyAMohantyDSahooK. Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy. Nanomedicine2010; 5: 433–449.
32.
FengSS. Nanoparticles of biodegradable polymers for new concept chemotherapy. Expert Rev Med Devices2004; 1: 115–125.
PignatelloRFrancescoCF. Calorimetric techniques to study the interaction of drugs with biomembrane models. J Pharm Bioallied Sci2011; 3: 1–2.
35.
VinogradovSBatrakovaEKabanovA. Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA–mPEG nanoparticles. Int J Pharm2003; 259: 115–127.
36.
AcharyaSDilnawazFSahooSK. Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Biomaterials2009; 30: 5737–5750.
37.
MohantyCSahooK. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials2010; 1: 6597–6611.
38.
HorbettTABrashJL. Proteins at interfaces. Physicochemical and biochemical studies. In: HorbettTABrashJL (eds) Proteins at interfaces , Washington, DC: American Chemical Society, 1987, pp. 1–33.
39.
HorbettTA. Principles underlying the role of adsorbed plasma proteins in blood interactions with foreign materials. Cardiovasc Pathol1993; 2: 137–148.
40.
JeonSILeeJHAndradeJDDe GennesPG. Protein-surface interactions in the presence of polyethylene oxide: I. Simplified theory. J Colloid Interface Sci1991; 142: 149–158.
41.
YokoyamaM. Novel passive targetable drug delivery with polymeric micelles. In: OkanoT (ed.) Biorelated polymers and gels , San Diego, CA: Academic Press, 1998, pp. 193–229.
42.
RichardAM. Plasma hemoglobin measurement techniques for the in vitro evaluation of blood damage caused by medical devices. Artif Organs1997; 21: 1255–1267.
43.
RekhaMRSharmaCP. Hemocompatible pullulan–polyethyleneimine conjugates for liver cell gene delivery: in vitro evaluation of cellular uptake, intracellular trafficking and transfection efficiency. Acta Biomater2011; 7: 370–379.
44.
ChoudhuriTPalSAgwarwalMLDasTSaG. Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett2002; 512: 334–340.
MaoCLiangCXMaoYQLiLHouXMShenJ. Modification of polyethylene with Pluronics F127 for improvement of blood compatibility. Colloids Surf B: Biointerfaces2009; 74: 362–365.
47.
WangYJPanMHChengALLinLIHoYSHsiehCY. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal1997; 15: 1867–1876.
48.
LeungMHMColangeloHKeeTW. Encapsulation of curcumin in cationic micellae suppresses alkaline hydrolysis. Langmuir2008; 24: 5672–5675.
49.
Lev-AriSStrierLKazanovD. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clin Cancer Res2005; 11: 6738–6744.
50.
MaZHaddadiAMolaviOLavasanifarALaiRSamuelJ. Micelles of poly(ethylene oxide)-b-poly(e-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. J Biomed Mater Res A2008; 86: 300–310.
51.
Lev-AriSStrierLKazanovD. Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells. Rheumatology2006; 45: 171–177.
52.
Lev-AriSVexlerAStarrA. Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines. Cancer Invest2007; 25: 411–418.
53.
YanFZhangCZhengY. The effect of Poloxamer 188 on nanoparticle morphology, size, cancer cell uptake and cytotoxicity. Nanomedicine: NBM2010; 6: 170–178.
54.
MeiLZhangYZhengY. A novel docetaxel-loaded poly(ε-caprolactone)/Pluronic F68 nanoparticle overcoming multidrug resistance for breast cancer treatment. Nanoscale Res Lett2009; 4: 1530–1539.
55.
BatrakovaEVLiSVinogradovSVAlakhovVYMillerDWKabanovAV. Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization. J Pharmacol Exp Ther2001; 299: 483–493.
56.
SahayGBatrakovaEVKabanovAV. Different internalization pathways of polymeric micelles and unimers and their effects on vesicular transport. Bioconjugate Chem2008; 19: 2023–2029.
57.
ShinIGKimSYLeeYMChoCSSungYK. Methoxy poly (ethylene glycol)/ε-caprolactone amphiphilic block copolymeric micelle containing indomethacin: I. Preparation and characterization. J Contr Release1998; 51: 1–11.
58.
KimSYShinIGLeeYM. Preparation and characterization of biodegradable nanospheres composed of methoxy poly(ethylene glycol) and DL-lactide block copolymer as novel drug carriers. J Contr Release1998; 56: 197–208.
